Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04076813 · ClinicalTrials.gov registry record

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

A clinical trial of Myocardial Infarction, sponsored by Chiesi USA.

Active
Registry status
5,050
Enrollment target
11
Study locations

NCT04076813 is a study of Myocardial Infarction that is active but no longer recruiting, run by Chiesi USA. The registered enrollment target is 5,050 participants, above the 4,603-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (10% higher). The trial reports 11 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04076813, a study of Myocardial Infarction, is active but no longer recruiting, sponsored by Chiesi USA.

ACTIVE NOT RECRUITING
Registry status
5,050 participants
Enrollment target
11
Study locations

Study Summary

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Conditions Studied

Study Locations (11)

California

  • The Regents of the University of California on behalf of its San Diego campus - La Jolla

Delaware

  • Christiana Care Health Services, Inc. - Newark

Florida

  • University of Florida - Gainesville

Idaho

  • Kootenai Hospital District dba Kootenai Health - Coeur d'Alene

Maryland

  • MedStar Health Research Institute, Inc. - Hyattsville

Massachusetts

  • The Brigham and Women's Hospital, Inc. - Boston

Michigan

  • Henry Ford Health System - Detroit

Missouri

  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 5,050 participants
Start Date 2019-10-16
Est. Completion 2025-06-30

Sponsor

Chiesi USA

1 total trials

What the Registry Record Tells You About NCT04076813

The ClinicalTrials.gov registry entry for NCT04076813 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5,050 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,603-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (10% higher). The listed sponsor is Chiesi USA, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.

NCT04076813 reports 11 study locations spanning 11 distinct geographic areas - top geographies include California, Delaware, Florida.

Frequently Asked Questions

What is clinical trial NCT04076813 about?

NCT04076813 is a clinical study titled "Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry". The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

What is the current status of trial NCT04076813?

This trial is currently active not recruiting. The enrollment target is 5,050 participants. The study started on 2019-10-16. Estimated completion is 2025-06-30.

What conditions does trial NCT04076813 study?

This clinical trial studies the following conditions: Myocardial Infarction.

Who is sponsoring clinical trial NCT04076813?

This trial is sponsored by Chiesi USA, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04076813 being conducted?

This trial has 11 study locations across California, Delaware, Florida, Idaho, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.